✦ LIBER ✦

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

✍ Scribed by Grode, Leander; Ganoza, Christian A.; Brohm, Christiane; Weiner, January; Eisele, Bernd; Kaufmann, Stefan H.E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a quadrival

✍ Yadav, Sangeeta; Manglani, M. V.; Ashwath Narayan, D. H.; Sharma, S.; Ravish, H. 📂 Article 📅 2014 🏛 Indian Academy of Pediatrics 🌐 English ⚖ 483 KB

A Phase I, randomized, open-label study

✍ Cheng, Aristine; Fung, Chang-Phone; Liu, Chia-Chyi; Lin, Yi-Tsung; Tsai, Hsih-Ye 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 768 KB

DNA priming and influenza vaccine immuno

✍ Julie E Ledgerwood; Chih-Jen Wei; Zonghui Hu; Ingelise J Gordon; Mary E Enama; C 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 268 KB

Randomized clinical trial of immunogenic

✍ David L. Gordon; Dimitar Sajkov; Richard J. Woodman; Yoshikazu Honda-Okubo; Mano 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 363 KB

Safety and preliminary immunogenicity of

✍ Dotres, Carlos P.; Puga, Rinaldo; Ricardo, Yariset; Broño, Carmen R.; Paredes, B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 303 KB

First-in-human phase 1 trial of the safe

✍ SR Walsh, MS Seaman, JA Johnson, RP Tucker, KH Krause, M Weijtens, MG Pau… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 65 KB